MXCTMAXCYTE, INC.vs its industry peers
A metric-by-metric comparison of MAXCYTE, INC. against SIC 8731 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MXCTEsta | $150M#6 | — | 0.9x#1 | 7.1x#3 | -5.7%#6 | -8.7%#5 | -247.6%#5 | -28.1%#4 | — | — | -9.9%#5 | — |
| INCY | $24.0B#1 | 60.0x#2 | 4.2x#2 | 4.7x#2 | 21.2%#3 | 3846.9%#1 | 29.5%#1 | 22.8%#2 | 45.1%#1 | — | 15.8%#3 | — |
| MEDP | $18.6B#2 | 36.8x#1 | 31.7x#5 | 7.3x#4 | 20.0%#4 | 11.6%#4 | 21.1%#2 | 77.1%#1 | — | — | 11.8%#4 | — |
| CRL | $16.8B#3 | — | 5.9x#3 | 4.2x#1 | -0.9%#5 | -750.1%#7 | 0.6%#3 | -5.1%#3 | 0.6%#2 | — | 96.8%#2 | — |
| ABSI | $1.7B#4 | — | 7.0x#4 | 612.9x#6 | -38.2%#7 | -11.7%#6 | -4297.0%#7 | -46.8%#5 | -84.6%#3 | — | 143.9%#1 | — |
| ONMD | $251M#5 | — | — | 184.5x#5 | 111.4%#1 | 72.3%#2 | -711.3%#6 | — | — | 4#1 | -76.1%#6 | — |
| CBIH | — | — | — | — | 21.8%#2 | 15.7%#3 | -139.1%#4 | — | — | 3#2 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 8731). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice